Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
GEA Group AG is a leading international technology group and one of the world's largest suppliers of systems, machinery, plants, advanced process technology, components, and comprehensive services primarily to the food, beverage, and pharmaceutical industries. Founded in 1881 and headquartered in Düsseldorf, Germany, the company operates through key divisions including Separation & Flow Technologies, Liquid & Power Technologies, Food & Health Technologies, Farm Technologies, and Heating & Refrigeration Technologies, serving over 150 countries with more than 18,000 employees and generating approximately €5.4 billion in revenue in fiscal year 2024. Its portfolio encompasses separators, decanters, homogenizers, valves, pumps, brewing systems, liquid processing, filling, concentration, fermentation, drying, powder handling, packaging, meat processing, milking systems, refrigeration, and energy-efficient solutions for dairy, chemical, new food, oil & gas, and marine sectors. GEA emphasizes sustainability, digitalization, AI, and innovation to enhance production efficiency, reduce emissions, and support net-zero goals, holding a prominent position in indices like the DAX, STOXX Europe 600, and various ESG benchmarks. Through its global presence and service offerings, GEA plays a vital role in optimizing industrial processes and fostering responsible engineering for nutrition and health worldwide.
10.81% operating margin is respectable but not wide. ROIC at 15.13%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue growth slowed to 1.4%, essentially flat. This is a business that needs a catalyst.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€5.51B
▲ +1.4% YoY
Net Income (TTM)
€419M
▲ +7.5% YoY
Op. Margin
10.88%
▲ +0.9pp YoY
ROIC
15.13%
Cash Flow & Balance Sheet
FCF (TTM)
€369M
▲ +0.7% YoY
Op. Cash Flow (TTM)
€492M
▼ -8.2% YoY
Net Debt
-€366M
Net Cash Position
Cash & Equiv.
€613M
3Y CAGR: +2.1%
3Y CAGR: +21.5%
Continue Research